Related Experiment Videos
Rheumatic manifestations of hyperlipidaemia
1Arthritis and Inflammation Research Programme, University of New South Wales, Australia.
Insights
Familial hypercholesterolaemia (FH) causes high cholesterol and early cardiovascular issues. Homozygous FH patients experience more frequent and earlier onset of cardiovascular and rheumatological symptoms compared to heterozygous patients.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Rheumatology
Background:
- Familial hypercholesterolaemia (FH) is a genetic disorder.
- Characterized by extremely high serum cholesterol levels from birth.
- Leads to premature atherosclerosis and cardiovascular disease.
Purpose of the Study:
- To describe the clinical and rheumatological manifestations of familial hypercholesterolaemia.
- To compare the disease severity in homozygous versus heterozygous FH patients.
Main Methods:
- Review of clinical characteristics.
- Analysis of patient data including serum cholesterol, cardiovascular events, and rheumatological symptoms.
Main Results:
- FH presents with elevated serum cholesterol, tendon xanthomas, xanthelasmas, arcus corneae, and premature atherosclerosis.
- Rheumatological manifestations include polyarthritis and tendinitis.
- Homozygous FH patients exhibit more frequent and earlier onset of cardiovascular and rheumatological manifestations than heterozygous patients.
Conclusions:
- Familial hypercholesterolaemia has significant cardiovascular and rheumatological impacts.
- Disease severity is notably greater in individuals with homozygous FH.
- Early diagnosis and management are crucial for mitigating complications.
Abstract:
Familial hypercholesterolaemia is characterized by elevated serum cholesterol, tendon xanthomas, xanthelasmas, arcus corneae and premature atherosclerosis. Rheumatological manifestations include acute episodes of polyarthritis and tendinitis. Patients who are homozygous for familial hypercholesterolaemia have cardiovascular and rheumatological manifestations more frequently and at an earlier age than patients who are heterozygous.